Jacobs Levy Equity Management’s Tenet Healthcare THC Stock Holding History

Jacobs Levy Equity Management’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35M	Buy	12,575 +4,856	+63%	+$893K	0.01%	561
2026 Q1	$1.46M	Buy	7,719 +6,705	+661%	+$1.41M	0.01%	643
2025 Q4	$202K	Hold	1,014	–	–	﹤0.01%	884
2025 Q3	$206K	Buy	+1,014	New	+$180K	﹤0.01%	917
2024 Q1	–	Sell	-377,790	Closed	-$28.5M	–	1053
2023 Q4	$28.5M	Sell	377,790 -409,062	-52%	-$25.9M	0.14%	161
2023 Q3	$51.8M	Buy	786,852 +25,077	+3%	+$1.87M	0.31%	75
2023 Q2	$62M	Sell	761,775 -33,171	-4%	-$2.36M	0.36%	74
2023 Q1	$47.2M	Buy	794,946 +624,452	+366%	+$34.7M	0.29%	88
2022 Q4	$8.32M	Buy	+170,494	New	+$7.88M	0.06%	309
2022 Q2	–	Sell	-19,738	Closed	-$1.7M	–	1087
2022 Q1	$1.7M	Sell	19,738 -113,819	-85%	-$9.35M	0.01%	654
2021 Q4	$10.9M	Sell	133,557 -22,356	-14%	-$1.63M	0.07%	284
2021 Q3	$10.4M	Buy	155,913 +59,526	+62%	+$4.22M	0.07%	291
2021 Q2	$6.46M	Buy	96,387 +88,586	+1,136%	+$5.49M	0.04%	393
2021 Q1	$406K	Sell	7,801 -77,332	-91%	-$3.91M	﹤0.01%	890
2020 Q4	$3.4M	Buy	85,133 +40,323	+90%	+$1.3M	0.03%	469
2020 Q3	$1.1M	Sell	44,810 -1,954	-4%	-$49.9K	0.01%	643
2020 Q2	$847K	Sell	46,764 -193,462	-81%	-$3.81M	0.01%	702
2020 Q1	$3.46M	Buy	240,226 +163,200	+212%	+$4.68M	0.04%	363
2019 Q4	$2.93M	Buy	+77,026	New	+$2.31M	0.03%	475
2019 Q3	–	Sell	-354,514	Closed	-$7.32M	–	999
2019 Q2	$7.32M	Buy	354,514 +40,650	+13%	+$937K	0.1%	259
2019 Q1	$9.05M	Buy	+313,864	New	+$7.75M	0.13%	202
2017 Q1	–	Sell	-64,800	Closed	-$962K	–	998
2016 Q4	$962K	Sell	64,800 -61,300	-49%	-$1.1M	0.02%	562
2016 Q3	$2.86M	Buy	+126,100	New	+$3.28M	0.05%	357

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jacobs Levy Equity Management's THC Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Tenet Healthcare (THC) stake by 63% in Q2 2026, buying an estimated $893K and bringing the position to 12,575 shares worth $2.35M. The position accounts for 0.01% of the portfolio, ranked #561.

Jacobs Levy Equity Management first reported a position in THC in Q3 2016 and has held it in 23 quarters since. The position peaked at $62M in Q2 2023. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Jacobs Levy Equity Management held 12,575 shares of Tenet Healthcare worth $2.35M as of Q2 2026.
Jacobs Levy Equity Management bought 4,856 Tenet Healthcare shares in Q2 2026, an estimated $893K.
Tenet Healthcare made up 0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #561 holding.
Jacobs Levy Equity Management first reported a position in Tenet Healthcare in Q3 2016 and has held it in 23 quarters since.
Jacobs Levy Equity Management's Tenet Healthcare position peaked at $62M in Q2 2023.
679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.